MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned...
Read moreCartier Resources Inc. (″ Cartier ″ or the ″ Company ″) (TSXV: ECR,OTC:ECRFF; FSE: 6CA) is pleased to announce the...
Read moreUnited States Antimony (NYSE:UAMY) said on Sunday (October 19) that it is proposing to acquire Australian company Larvotto Resources (ASX:LRV)....
Read more(TheNewswire) In addition, the Qualified Person (QP) for the project and author of the NI43-101 report, Jorge Ortega, P.Geo., continues...
Read moreNextech3D.ai (CSE:NTAR)(OTCQX:NEXCF)(FSE:1SS), an AI-first technology company specializing in event management, 3D modeling, and spatial computing, is pleased to announce the...
Read moreSilver Hammer Mining Corp. (CSE: HAMR) (the ‘Company‘ or ‘Silver Hammer‘) is pleased to announce it has entered into an...
Read moreManhattan Showing with assay results returning uranium grades ranging from 0.72% to 8.10% U3O8 in outcrop grab samples. Standard Uranium...
Read moreJindalee Lithium (JLL:AU) has announced Proposed issue of securities – JLL Download the PDF here. This post appeared first on...
Read moreTrading resumes in: Company: Cardiol Therapeutics Inc. TSX Symbol: CRDL All Issues: Yes Resumption (ET): 8:00 AM CIRO can make...
Read more(TheNewswire) NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia...
Read more